⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24092196 | 0.88 | — | — | |
| SCHEMBL24599776 | 0.71 | — | — | |
| SCHEMBL18456687 | 0.70 | — | — | |
| SCHEMBL19216088 | 0.70 | — | — | |
| SCHEMBL7778101 | 0.64 | BCHE (0.33) | — | |
| SCHEMBL5177835 | 0.64 | ADH1B (0.31) | — | |
| SCHEMBL18756282 | 0.64 | CYP2D6 (0.36) | — | |
| SCHEMBL22851396 | 0.62 | — | — | |
| SCHEMBL25795085 | 0.61 | CYP2D6 (0.34) | — | |
| SCHEMBL3698430 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11834482-B2 | Agents modulating beta-catenin functions and methods thereof | FOG PHARMACEUTICALS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-20220213154-A1 | AGENTS MODULATING BETA-CATENIN FUNCTIONS AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2022-07-07 | — | — | US | disclosed |